Mucosal vaccination with recombinant poxvirus vaccines protects ferrets against symptomatic CDV infection

Vaccine

Volumn 17, Issue 4, 1999, Pages 308-318

  Welter, Janet ^a   Taylor, Jill ^b   Tartaglia, James ^b   Paoletti, Enzo ^b   Stephensen, Charles B ^a,c  

^a UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^b Virogenetics Corporation   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Distemper; Mucosal vaccination; Recombinant poxviruses

Indexed keywords

VIRUS GLYCOPROTEIN; VIRUS HEMAGGLUTININ; VIRUS RNA; VIRUS VACCINE;

ANIMAL CELL; ARTICLE; CANINE DISTEMPER MORBILLIVIRUS; CONTROLLED STUDY; DOG DISEASE; DRUG EFFICACY; FERRET; FEVER; IMMUNITY; INTRADUODENAL DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; LEUKOPENIA; NONHUMAN; POXVIRUS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL; VACCINATION; VACCINIA VIRUS; VIRUS RECOMBINANT;

ANIMALS; ARTIFICIAL GENE FUSION; AVIPOXVIRUS; DISEASE MODELS, ANIMAL; DISTEMPER; DISTEMPER VIRUS, CANINE; DUODENUM; FERRETS; HEMAGGLUTININS; INTESTINAL MUCOSA; MEASLES; NASAL MUCOSA; NEUTRALIZATION TESTS; VACCINES, ATTENUATED; VACCINIA VIRUS;

EID: 0345267358     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00211-4     Document Type: Article

References (48)

1. Stephensen C.B., Welter J., Thaker S., Taylor J., Tartaglia J., Paoletti E. Canine distemper virus (CDV) infection of ferrets as a model for testing Morbillivirus vaccine strategies: NYVAC- and ALVAC-based CDV recombinants protect against symptomatic infection. J Virol. 71(2):1997;1506-1513.
2. Etchart N., Wild F., Kaiserlian D. Mucosal and systemic immune responses to measles virus haemagglutinin in mice immunized with a recombinant vaccinia virus. J Gen Virol. 77:1996;2471-2478.
3. van Binnendijk R.S., Poelen M.C.M., van Amerongen G., de Vries P., Osterhaus A.D.M.E. Protective immunity in macaques vaccinated with live attenuated, recombinant and subunit measles vaccines in the presence of passively acquired antibodies. J Infect Dis. 175:1997;524-532.
4. Murphy BR, Collins PG, Chanock RM. Intranasal immunization with vaccinia-RS virus recombinant viruses is superior to intradermal immunization in animals with passively acquired RS virus antibodies. Vaccines 1989:501-505.
5. Taylor J., Pincus S., Tartaglia J., Richardson C., Alkhatib G., Briedis D., Appel M., Norton E., Paoletti E. Vaccinia virus recombinants expressing either the measles virus fusion or hemagglutinin glycoprotein protect dogs against canine distemper virus challenge. J Virol. 65:1991;4263-4274.
6. Ngichabe C., Wamway H., Barrett T., Ndungu E., Black D., Bostock C. Trial of a capripox-rinderpest recombinant vaccine in African cattle. Epidemiol Infect. 118:1997;63-70.
7. Jones L., Tenorio E., Gorham J., Yilma T. Protective vaccination of ferrets against canine distemper with recombinant pox virus vaccines expressing the H or F genes of rinderpest virus. Am J Vet Res. 58(6):1997;590-593.
8. Tartaglia J., Perkus M.E., Taylor J., Norton E.K., Audonnet J.C., Cox W.I., Davis S.W., van der Hoeven J., Meignier B., Riviere M., Languet B., Paoletti E. NYVAC: a highly attenuated strain of vaccinia virus. Virology. 188:1992;217-232.
9. Taylor J., Weinberg R., Tartaglia J., Richardson C., Alkhatib G., Briedis D., Appel M., Norton E., Paoletti E. Nonreplicating viral vectors as potential vaccines: recombinant canarypox virus expressing measles virus fusion (F) and hemagglutinin (HA) glycoproteins. Virology. 187:1992;321-328.
10. Taylor J., Meignier B., Tartaglia J., Languet B., VanderHoeven J., Franchini G., Trimarchi C., Paoletti E. Biological and immunogenic properties of a canarypox-rabies recombinant, ALVAC-RG (vCP65) in non-avian species. Vaccine. 13:1995;539-549.
11. Perkus M.E., Limbach K., Paoletti E. Cloning and expression of foreign genes in vaccinia virus using a host-range selection system. J Virol. 63:1989;3829-3836.
12. Appel M., Robson D.S. A microneutralization test for canine distemper virus. Am J Vet Res. 34:1973;1459-1463.
13. Appel M.J.G., Pearce-Kelling S., Summers B.A. Dog lymphocyte cultures facilitate the isolation and growth of virulent canine distemper virus. J Vet Diagnostics Invest. 4:1992;258-263.
14. Rozenblatt S., Eizenberg O., Ben-Levy R., Lavie V., Bellini W.J. Sequence homology within the morbilliviruses. J Virol. 53:1985;684-690.
15. Boom R., Sol C.J.A., Salimans M.M.M., Jansen C.L., Dillen P.M.E.W., Noordaa J.V. Rapid and simple method for purification of nucleic acids. J Clin Microbiol. 28:1990;495-503.
16. Park J., Peters C.J., Rollin P.E., Ksiazek T.G., Gray B., Waites K.B., Stephensen C.B. Development of an RT-PCR assay for diagnosis of lymphocytic choriomeningitis virus (LCMV) infection and its use in a prospective surveillance study. J Med Virol. 51:1997;107-114.
17. Norrby E., Utter G., Orvell C., Appel M.J. Protection against canine distemper virus in dogs after immunization with isolated fusion protein. J Virol. 58:1986;536-541.
18. de Vries P., Vanbinnendijk R.S., Vandermarcel P.et al. Measles virus fusion protein presented in an immune-stimulating complex (Iscom) induces haemolysis-inhibiting antibodies, virus-specific T cells and protection in mice. J Gen Virol. 69:1988;549-559.
19. Holmgren J., Czerkinsky C., Lycke N., Svennerholm A. Mucosal immunity: implications for vaccine development. Immunobiology. 184:1992;157-179.
20. Norrby E, Oxman MN. Measles virus. In: Fields BN, Knipe DM, Chanock RM, Hirsch MS, Melnick JL, Monath TP, Roizman B, editors. Fields virology, 2nd ed., vol. I. New York: Raven Press, 1990. p. 1013-44.
21. Garenne M., Aaby P. Pattern of exposure and measles mortality in Senegal. J Infect Dis. 161:1990;1088-1094.
22. World Health Organization, Expanded Programme on Immunization, Global Advisory Group. Revised plan of action for global measles control. WHO working paper No. 10, 1993.
23. Aaby P., Samb B., Simondon F., Knudsen K., Seck A.M.C., Bennett J., Whittle H. Divergent mortality for male and female recipients of low-titer and high-titer measles vaccines in rural Senegal. Am J Epidemiol. 138(9):1993;746-755.
24. Garenne M., Leroy O., Beau J.P., Sene I. Child mortality after high-titre measles vaccines: prospective study in Senegal. Lancet. 338:1991;903-907.
25. Sabin A.B. Vaccination at the portal of entry of infectious agents. Dev Biol Stand. 33:1976;3.
26. McGhee J.R., Mestecky J. In defense of mucosal surfaces: development of novel vaccines for IgA responses protective at the portals of entry of microbial pathogens. Infect Dis Clin North Am. 4(2):1990;315-341.
27. Khanum S., Uddin N., Garelick H., Mann G., Tomkins A. Comparison of Edmonston-Zagreb and Schwarz strains of measles vaccine given by aerosol or subcutaneous injection. Lancet. January 17:1987;150-153.
28. Sabin A.B., Albrecht P., Takeda A.K., Ribeiro E.M., Veronesi R. High effectiveness of aerosolozed chick embryo fibroblast measles vaccine in seven-month-old and older infants. J Infect Dis. 152(6):1985;1231-1237.
29. Sabin A.B., Flores Arechiga A., Fernandez de Castro J., Sever J.L., Madden D.L., Shekarchi I., Albrecht P. Successful immunization of children with and without maternal antibody by aerosolized measles vaccine. I. Different results with undiluted human diploid cell and chick embryo fibroblast vaccines. J Am Med Assoc. 249:1983;2651-2662.
30. Salmi A.A. Suppression of T-cell immunity after measles infection: is the puzzle solved? Trends Microbiol. 5(3):1997;85-86.
31. Hussey G.D., Goddard E.A., Hughes J., Ryon J.J., Kerran M., Carelse E., Strebel P.M., Markowitz L.E., Moodie J., Barron P., Latief Z., Sayed R., Beatty D., Griffin D.E. The effect of Edmonston-Zagreb and Schwarz measles vaccines on immune responses in infants. J Infect Dis. 173:1996;1320-1326.
32. Osterhaus A.D.M.E., de Vries P. Vaccination against acute respiratory virus infections and measles in man. Immunobiology. 184:1992;180-192.
33. DeLay P.D., Stone S.S., Karzon D.T., Katz S., Enders J. Clinical and immune response of alien hosts to inoculation with measles, rinderpest and canine distemper viruses. Am J Vet Res. 26:1965;1359-1373.
34. Liu C., Coffin D.L. Studies on canine distemper infection by means of fluorescein-labeled antibody. I. The pathogenesis, pathology, and diagnosis of the disease in experimentally infected ferrets. Virology. 3:1957;115-131.
35. Crook E, Gorham JR, McNutt SH. Experimental distemper in mink and ferrets. I. Pathogenesis. Am J Vet Res 1958:955-957.
36. Kauffman C.A., Bergman A.G., O'Connor R.P. Distemper virus infection in ferrets: an animal model of measles-induced immunosuppression. Clin Exp Immunol. 47:1982;617-625.
37. Beauverger P., Buckland R., Wild T.F. Measles virus antigens induce both type-specific and canine distemper virus cross-reactive cytotoxic T-lymphocytes in mice: localization of a common Ld-restricted nucleoprotein epitope. J Gen Virol. 74:1993;2357-2363.
38. Krakowka S., Wallace A.L. Lymphocyte-associated immune responses to canine distemper and measles viruses in distemper-infected gnotobiotic dogs. Am J Vet Res. 40:1979;669-672.
39. Stephenson J.R., ter Meulen V. Antigenic relationships between measles and canine distemper viruses: comparison of immune response in animals and humans to individual virus-specific polypeptides. Proc Natl Acad Sci U.S.A. 76:1979;6601-6605.
40. Brown A.L., McCarthy R.E. Relationship between measles and canine distemper viruses determined by delayed type hypersensitivity reactions in dogs. Nature. 248:1974;344-345.
41. Giraudon P., Wild T.F. Correlation between epitopes on hemagglutinin of measles and biological activities: passive protection by monoclonal antibodies is related to their hemagglutination inhibiting activity. Virology. 144:1985;46-58.
42. Bankamp B., Brinckmann U.G., Reich A., Niewiesk S., ter Meulen V., Liebert U.G. Measles virus nucleocapsid protein protects rats from encephalitis. J Virol. 65:1991;1695-1700.
43. Brinckmann U.G., Bankamp B., Reich A., ter Meulen V., Liebert U.G. Efficacy of individual measles virus structural proteins in the protection of rats from measles encephalitis. J Gen Virol. 72:1991;2491-2500.
44. Wild T.F., Bernard A., Spehner D., Villeval D., Drillien R. Vaccination of mice against canine distemper virus-induced encephalitis with vaccinia virus recombinants encoding measles or canine distemper virus antigens. Vaccine. 11:1993;438-444.
45. Thormar H., Mehta P.D., Barshatzky M.R., Brown H.R. Measles virus encephalitis in ferrets as a model for subacute sclerosing panencephalitis. Lab Anim Sci. 35:1985;229-232.
46. Wyde P.R., Ambrose M.W., Voss T.G., Meyer H.L., Gilbert B.E. Measles virus replication in lungs of hispid cotton rats after intranasal inoculation. Proc Soc Exp Biol Med. 201:1992;80-87.
47. Niewiesk S., Eisenhuth I., ter Muelen V. Protective immunity, but suppressed immune responses to third party antigens are generated in cotton rats during measles virus infection. Biochem Soc Trans. 25:1997;355S.
48. Horvat B., Rivailler P., Varior-Krishnan G., Cardoso A., Gerlier D., Rabourdin-Combe C. Transgenic mice expressing human measles virus (MV) receptor CD46 provide cells exhibiting different permissivities to MV infection. J Virol. 70:1996;6673-6681.